In the first season following the introduction of a new maternal respiratory syncytial virus (RSV) vaccine, data presented at the 2025 American College of Obstetricians and Gynecologists (ACOG) Annual ...

Most videos on TikTok regarding hormonal contraception were misleading, according to a study presented at the 2025 ACOG Annual Clinical and Scientific Meeting. Millions turn to TikTok for health ...

NVX-CoV2705 is indicated for individuals aged 12 to 64 years with an underlying condition that poses high risk for severe COVID-19 outcomes. Approval was based on phase 3 trials showing strong ...

Colleen Sloan, PA-C, RDN, highlights what she is seeing in practice related to screen time, devices, and social media and impacts on nutrition. Colleen Sloan, PA-C, RDN, registered dietitian in ...

Severe RSV disease in 2022–2023 was most likely to occur in infants under 6 months and older children with pulmonary or neurologic conditions. Infants younger than 6 months and premature babies had ...

Delandistrogene moxeparvovec-rokl (ELEVIDYS) showed significant motor function improvements in 8- to 9-year-old Duchenne muscular dystrophy patients in part 2 of the phase 3 EMBARK study. In part 2 of ...

Youth nicotine pouch use and dual use with e-cigarettes increased from 2023 to 2024, highlighting the need for stronger prevention and regulation efforts. From 2023 to 2024, past-30-day nicotine pouch ...

Music therapist Jenna Marcovitz discusses the role of pediatricians in making timely referrals to music therapy to support whole-child health. Music therapy can support pediatric patients across ...

Maternal avocado consumption during pregnancy was linked to significantly lower odds of infant food allergy at 12 months. Maternal consumption of avocado during pregnancy was associated with ...

Zhang Meng shares how advancements in technology have helped prevent early cavities in childhood, and how to counsel your young patients on good oral health. Technology is king these days, starting at ...

Somapacitan was non-inferior and had a similar safety profile and clinical outcomes compared to once-daily somatropin in improving yearly growth rates. Once-weekly somapacitan matched or outperformed ...

"These findings support Advisory Committee on Immunization Practices’ recommendations for maternal vaccination or nirsevimab to protect against severe RSV disease in infants," wrote the MMWR study ...